NCT06325566Phase 3Active not recruiting

Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain

Study sponsor: Mesoblast, Ltd. · MESO

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-07Estimated
Enrollment · participants300Estimated
Source updated2026-06-17Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Primary completion date changed

Before: Oct 2026. After: Jul 2027.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview